IP Library Granted Patent US 9,604,903
Granted Patent B2
US 9,604,903 · App. 14/383,348 · Granted Mar 28, 2017

Metathesis process

Inventors: Bastiaan Wels (Utrecht, NL); Hans Ridderikhoff (Gouda, NL); Tanja Van Bergen-Brenkman (Gouda, NL); Dessy Liminto (The Hague, NL)
Assignee: CRODA INTERNATIONAL PLC
C07C67/475B01J31/128B01J31/146B01J31/2273B01J31/2278C07C1/213C07C6/02C07C6/04C07C51/373C07C67/27C11C3/00B01J2231/54B01J2531/821C07C2527/135C07C2531/12C07C2531/22C07C2531/30C10G2300/1014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,604,903
App. No.
14/383,348
Granted
Mar 28, 2017
Kind
B2
Abstract

A process of metathesizing a feedstock in the presence of a metathesis catalyst and at least one catalyst enhancer. The catalyst enhancer can be selected from a sacrificial catalyst or a non-catalyst enhancer. The process exhibits improved reaction times and/or the metathesis catalyst can be used at very low concentrations.

Claims (39)

1. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture,

wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer,

wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II),

wherein the non-catalyst enhancer is selected from the group consisting of a Lewis acid and a titanium based compound,

wherein the process is carried out without a solvent or in a solvent consisting of hydrocarbons and/or alcohols, wherein the metathesis catalyst efficiency is less than 100.

2. The process according to claim 1 wherein at least 40 wt. % of the feedstock is metathesized.

3. The process according to claim 1 wherein the process reaches equilibrium in less than 20 minutes.

4. The process according to claim 1 wherein the metathesis catalyst is present in an amount less than 100 ppm with respect to the reaction mixture.

5. The process according to claim 4 wherein the metathesis catalyst is present in an amount less than 10 ppm with respect to the reaction mixture.

6. The process according to claim 1 wherein the metathesis catalyst efficiency is less than 10.

7. The process according to claim 1 wherein the metathesis catalyst retains over 75% of its activity after 30 minutes.

8. The process according to claim 1 wherein no chemical treatment of the feedstock or starting material to remove catalyst poisons is performed.

9. The process according to claim 1 wherein the sacrificial catalyst is a sacrificial metathesis catalyst different from the metathesis catalyst.

10. The process according to claim 1 wherein the sacrificial catalyst is present in an amount ranging from 1 ppm to 100 ppm with respect to the reaction mixture.

11. The process according to claim 1 wherein the non-catalyst enhancer is a Lewis acid.

12. The process according to claim 1 wherein the non-catalyst enhancer is a titanium based compound.

13. The process according to claim 1 wherein the non-catalyst enhancer is selected from the group consisting of titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) propoxide, titanium (IV) isopropoxide, titanium (IV) butoxide, titanium (IV) tert-butoxide, titanium (IV) 2-ethylhexoxide, titanium (IV) 2-ethyl-1,3-hexanediolate, titanium (IV) tetrachloride, titanium (IV) tetrabromide, titanium (IV) tetrafluoride, titanium (IV) tetraiodide, and mixtures thereof.

14. The process according to claim 1 wherein the non-catalyst enhancer is present in an amount ranging from 10 ppm to 1,000 ppm with respect to the reaction mixture.

15. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture,

wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer,

wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II),

wherein the non-catalyst enhancer is selected from the group consisting of copper iodide, sodium iodide, tetrabutylgermanium, tetraethylsilicon, tin oxide, tin octoate, tin oxalate, dibutyltin dilaurate, tin(IV) chloridetetrabutyl orthotitanate, palladium acetate, tris(dibenzylideneacetone)palladium, tetrakis(triphenylphosphine)palladium, bis(diphenylferrocenyl)palladium dichloride, nickel chloride, bis(cyclooctadiene)nickel, nickelocene iron chloride, iron bromide, ferrocene, silver chloride, silver iodide, silver oxide, iodine, silver trifluoromethanesulfonate, sodium borohydride, boric acid, zinc ethylhexanoate, zircon (IV) oxide chloride octahydrate, acetic acid, butylated hydroxytoluene (BHT), quinones, activated charcoal, alumina, bleaching earth, titanium compounds having the general formula Ti.[Q] 4 wherein each Q independently represents hydrogen, a C 1 to C 10 alkoxy group, a C 4 to C 8 aryl group, a C 12 to C 18 fatty alcohol, or a C 6 to C 18 fatty acid,

wherein the non-catalyst enhancer is present in an amount ranging from 10 ppm to 1,000 ppm with respect to the reaction mixture.

16. The process according to claim 15 wherein the metathesis catalyst is present in an amount less than 100 ppm with respect to the reaction mixture.

17. The process according to claim 15 wherein the metathesis catalyst efficiency is less than 100.

18. The process according to claim 15 wherein no chemical treatment of the feedstock or starting material to remove catalyst poisons is performed.

19. The process according to claim 15 wherein the sacrificial catalyst is present in an amount ranging from 1 ppm to 100 ppm with respect to the reaction mixture.

20. The process according to claim 15 wherein the non-catalyst enhancer is a titanium compound having the general formula Ti.[Q] 4 wherein each Q independently represents hydrogen, a C 1 to C 10 alkoxy group, a C 4 to C 8 aryl group, a C 12 to C 18 fatty alcohol, or a C 6 to C 18 fatty acid.

21. The process according to claim 15 wherein the non-catalyst enhancer is selected from the group consisting of titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) propoxide, titanium (IV) isopropoxide, titanium (IV) butoxide, titanium (IV) tert-butoxide, titanium (IV) 2-ethylhexoxide, titanium (IV) 2-ethyl-1,3-hexanediolate, and mixtures thereof.

22. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture,

wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer,

wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II),

wherein the non-catalyst enhancer is selected from the group consisting of a Lewis acid and a titanium based compound,

wherein the process is carried out without a solvent or in a solvent consisting of hydrocarbons and/or alcohols,

wherein the metathesis catalyst retains over 75% of its activity after 30 minutes.

23. A process of metathesising a feedstock, wherein the feedstock comprises unsaturated fatty acids and/or esters of unsaturated fatty acids, in the presence of a metathesis catalyst and at least one catalyst enhancer compound in a reaction mixture,

wherein the at least one catalyst enhancer is selected from the group consisting of a sacrificial catalyst and a non-catalyst enhancer,

wherein the sacrificial catalyst is selected from the group consisting of dichloro-(3-phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(II), dichloro-(3-phenyl-1H-inden-1-ylidene)bis(isobutylphobane)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II), [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1H-inden-1-ylidene)(pyridyl)ruthenium(II), [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(4-methylphenyl)imino]methyl]-4-nitro-phenolyl]chloro-[3-phenyl-indenylidene]ruthenium(II), and [1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-[2-[[(2-methylphenyl)imino]methyl]-phenolyl]chloro-(3-phenyl-indenylidene)ruthenium(II),

wherein the non-catalyst enhancer is selected from the group consisting of titanium compounds having the general formula Ti.[Q] 4 wherein each Q independently represents hydrogen, a C 1 to C 10 alkoxy group, a C 4 to C 8 aryl group, a C 12 to C 18 fatty alcohol, or a C 6 to C 18 fatty acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2014
From: WELS, BASTIAAN; RIDDERIKHOFF, HANS; BERGEN-BRENKMAN, TANJA VAN; LIMINTO, DESSY
To: CRODA INTERNATIONAL PLC
Reel/Frame 033680/0248 →
Priority Claims (1)
GB 1204715.5 · Mar 18, 2012 · national
Continuity (1)
Related Publication 20150045568A1 · Feb 12, 2015